Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

36results about How to "Achieve high specificity detection" patented technology

Aptamer probe for detecting two kinds of tumor makers and electrochemical biosensor and preparation method and application thereof

The invention discloses an aptamer probe for detecting two kinds of tumor makers and an electrochemical biosensor and a preparation method and application thereof. The aptamer probe comprises an aptamer sequence, the aptamer sequence and the tumor marker I are subjected to specific recognition and closely bound, the 5' end and the 3' end of the aptamer probe are subjected to complementary hybridization to make the aptamer probe form a hairpin structure, and the stem portion of the hairpin structure comprises a recognition sequence of the tumor maker II and a recognition site of restriction enzyme. The electrochemical biosensor is prepared by fixing the aptamer probe on the surface of a working electrode. By means of the aptamer probe for detecting the two kinds of tumor makers and the electrochemical biosensor and the preparation method and application thereof, parallel analysis of multiple kinds of tumor marker molecules of thrombin and M.Sss I DNA methylation transferase can be achieved; the biosensor is high in detection sensibility, the lower detection limit for the thrombin is 0.1 ng / mL, and the lower detection limit for the M.Sss I DNA methylation transferase is 0.04 U / mL.
Owner:GUANGZHOU YUEWANG AGRI CO LTD

Fluorescent biosensor for detecting ochratoxin A as well as preparation method and application thereof

The invention relates to the technical field of biosensors, and particularly relates to a fluorescent biosensor for detecting ochratoxin A based on a rolling ring amplification mediated catalytic hairpin self-assembly and incision enzyme feedback amplification method. According to the fluorescent biosensor, as for a detection mode, a fluorescence method is adopted for detection, and a luminoscopeis utilized; before detection, a padlock probe and a connecting probe form an annular template probe; then a target object is added to a homogeneous solution of a complex probe I, a complex probe II,HP 2 and HP 3, incubating is carried out for 120 minutes at 37 DEG C, and the target object and an aptamer sequence are bound; the multiple feedback amplification process is completed under the actionof a phi29 DNA polymerase and an endonuclease IV, so that signal amplification is realized; and then, the luminoscope is used for setting the excitation wavelength to be 399 nm, the fluorescence intensity at 610 nm is detected, and the detection range is 560-640 nm. Meanwhile, the invention further provides a preparation method for the biosensor. The preparation method has the advantages of beingmild in reaction condition and easy to operate.
Owner:UNIV OF JINAN

CtDNA library construction and sequencing data analysis methods for simultaneously detecting common mutations of various liver cancers

The invention discloses ctDNA library construction and sequencing data analysis methods for simultaneously detecting common mutations of various liver cancers. The library construction method and thesequencing data analysis method have the following advantages: firstly, various mutation forms of liver cancers are simultaneously detected under the condition that capture is not needed; secondly, the methods are suitable for efficient capturing in an ultra-small target area; thirdly, the library can support 10 to 20 times of detection; fourthly, the DNA barcode is connected to an initial ctDNA molecule during the library construction process and the flow is analyzed by cooperating with a biological information analysis process to realize high-specificity detection of ctDNA low-frequency mutation; and fifthly, the library can be used for PCR hot spot detection and capture method sequencing at the same time, the false positive mutation can be filtered effectively by using the added DNA barcode to realize duplex-based high-specificity sequencing. The methods have the important clinical significance for early screening, disease tracking, curative effect evaluation, prognosis prediction and the like of liver cancers.
Owner:CANCER INST & HOSPITAL CHINESE ACADEMY OF MEDICAL SCI +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products